Related Experiment Videos
Immunohistochemical patterns in rectal cancer: application of tissue microarray with prognostic correlations
Eva Fernebro1, Pär-Ola Bendahl, Michael Dictor
1Department of Oncology, Jubileum Institute, University Hospital, Lund, Sweden. Eva.Fernebro@onk.lu.se
International Journal of Cancer
|August 10, 2004
Summary
Altered expression of beta-catenin and E-cadherin in rectal cancer correlates with metastatic disease. Most tested markers, including Ki-67 and EGFR, showed no prognostic value, suggesting limited utility of single markers.
Area of Science:
- Oncology
- Molecular Pathology
Background:
- Rectal cancer prognosis is complex, with a need for reliable biomarkers.
- Immunohistochemical markers are explored for their prognostic potential.
Purpose of the Study:
- To investigate immunohistochemical expression patterns of multiple markers in rectal cancer.
- To correlate these expression patterns with metastasis-free survival and prognosis.
Main Methods:
- High-throughput tissue microarray analysis of 269 rectal cancer samples.
- Immunostaining for Ki-67, Bcl-2, p53, EGFR, E-cadherin, beta-catenin, MLH1, and MSH2.
- Correlation of expression profiles with metastasis-free survival and clinicopathological factors.
Main Results:
- Ki-67, p53, Bcl-2, and EGFR expression did not correlate with prognosis.
- Reduced membranous or absent cytoplasmic staining for beta-catenin and E-cadherin correlated with metastatic disease.
- Multivariate analysis indicated increased risk of metastasis with altered beta-catenin and E-cadherin expression.
- Loss of MLH1 and MSH2 (MMR proteins) was rare.
Conclusions:
- Most tested markers lack prognostic value in rectal cancer.
- Altered expression of beta-catenin and E-cadherin shows potential prognostic importance for predicting metastatic disease.
- Prognostic assessment in rectal cancer may benefit from evaluating combinations of markers rather than single ones.